Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

52 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
When to initiate and discontinue biologic treatments for rheumatoid arthritis?
Chatzidionysiou K, van Vollenhoven RF. Chatzidionysiou K, et al. J Intern Med. 2011 Jun;269(6):614-25. doi: 10.1111/j.1365-2796.2011.02355.x. Epub 2011 Feb 23. J Intern Med. 2011. PMID: 21261760 Review.
Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries.
Chatzidionysiou K, Lie E, Nasonov E, Lukina G, Hetland ML, Tarp U, Gabay C, van Riel PL, Nordström DC, Gomez-Reino J, Pavelka K, Tomsic M, Kvien TK, van Vollenhoven RF. Chatzidionysiou K, et al. Ann Rheum Dis. 2011 Sep;70(9):1575-80. doi: 10.1136/ard.2010.148759. Epub 2011 May 12. Ann Rheum Dis. 2011. PMID: 21571731
Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration.
Chatzidionysiou K, Lie E, Nasonov E, Lukina G, Hetland ML, Tarp U, van Riel PL, Nordström DC, Gomez-Reino J, Pavelka K, Tomsic M, Kvien TK, van Vollenhoven RF, Gabay C. Chatzidionysiou K, et al. Ann Rheum Dis. 2012 Mar;71(3):374-7. doi: 10.1136/annrheumdis-2011-200003. Epub 2011 Oct 4. Ann Rheum Dis. 2012. PMID: 21972242
Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial.
van Vollenhoven RF, Geborek P, Forslind K, Albertsson K, Ernestam S, Petersson IF, Chatzidionysiou K, Bratt J; Swefot study group. van Vollenhoven RF, et al. Among authors: chatzidionysiou k. Lancet. 2012 May 5;379(9827):1712-20. doi: 10.1016/S0140-6736(12)60027-0. Epub 2012 Mar 29. Lancet. 2012. PMID: 22464340 Clinical Trial.
Rituximab versus anti-TNF in patients who previously failed one TNF inhibitor in an observational cohort.
Chatzidionysiou K, van Vollenhoven RF. Chatzidionysiou K, et al. Scand J Rheumatol. 2013;42(3):190-5. doi: 10.3109/03009742.2012.729607. Epub 2013 Jan 3. Scand J Rheumatol. 2013. PMID: 23286833
Rheumatoid arthritis. Triple therapy or etanercept after methotrexate failure in RA?
van Vollenhoven RF, Chatzidionysiou K. van Vollenhoven RF, et al. Among authors: chatzidionysiou k. Nat Rev Rheumatol. 2013 Sep;9(9):510-2. doi: 10.1038/nrrheum.2013.118. Epub 2013 Jul 30. Nat Rev Rheumatol. 2013. PMID: 23897440
Effectiveness of TNF inhibitor switch in RA: results from the national Swedish register.
Chatzidionysiou K, Askling J, Eriksson J, Kristensen LE, van Vollenhoven R; ARTIS group. Chatzidionysiou K, et al. Ann Rheum Dis. 2015 May;74(5):890-6. doi: 10.1136/annrheumdis-2013-204714. Epub 2014 Jan 15. Ann Rheum Dis. 2015. PMID: 24431398
Effectiveness and survival-on-drug of certolizumab pegol in rheumatoid arthritis in clinical practice: results from the national Swedish register.
Chatzidionysiou K, Kristensen LE, Eriksson J, Askling J, van Vollenhoven R; ARTIS Group. Chatzidionysiou K, et al. Scand J Rheumatol. 2015;44(6):431-7. doi: 10.3109/03009742.2015.1026840. Epub 2015 Jun 18. Scand J Rheumatol. 2015. PMID: 26084325
Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis.
Walker UA, Jaeger VK, Chatzidionysiou K, Hetland ML, Hauge EM, Pavelka K, Nordström DC, Canhão H, Tomšič M, van Vollenhoven R, Gabay C. Walker UA, et al. Among authors: chatzidionysiou k. Rheumatology (Oxford). 2016 Feb;55(2):230-6. doi: 10.1093/rheumatology/kev297. Epub 2015 Aug 27. Rheumatology (Oxford). 2016. PMID: 26316581
Effectiveness of tocilizumab with and without synthetic disease-modifying antirheumatic drugs in rheumatoid arthritis: results from a European collaborative study.
Gabay C, Riek M, Hetland ML, Hauge EM, Pavelka K, Tomšič M, Canhao H, Chatzidionysiou K, Lukina G, Nordström DC, Lie E, Ancuta I, Hernández MV, van Riel PL, van Vollenhoven R, Kvien TK. Gabay C, et al. Among authors: chatzidionysiou k. Ann Rheum Dis. 2016 Jul;75(7):1336-42. doi: 10.1136/annrheumdis-2015-207760. Epub 2015 Sep 15. Ann Rheum Dis. 2016. PMID: 26374404 Free PMC article.
52 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback